NEW YORK STATE COMMON RETIREMENT FUND - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 193 filers reported holding MYRIAD GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$2,119
-30.7%
132,125
+0.2%
0.00%
-25.0%
Q2 2023$3,058
+3.8%
131,907
+4.1%
0.00%0.0%
Q1 2023$2,945
+22.5%
126,772
-23.5%
0.00%
+33.3%
Q4 2022$2,404
-100.0%
165,705
-80.4%
0.00%
-87.0%
Q3 2022$16,094,000
+7.3%
843,514
+2.2%
0.02%
+15.0%
Q2 2022$14,998,000
-20.9%
825,451
+9.7%
0.02%0.0%
Q1 2022$18,956,000
-8.5%
752,235
+0.2%
0.02%
-4.8%
Q4 2021$20,712,000
-26.7%
750,452
-14.2%
0.02%
-30.0%
Q3 2021$28,254,000
+4.4%
875,004
-1.1%
0.03%
+7.1%
Q2 2021$27,069,000
-13.5%
885,179
-13.8%
0.03%
-20.0%
Q1 2021$31,284,000
+43.9%
1,027,377
-6.6%
0.04%
+45.8%
Q4 2020$21,744,000
+94.6%
1,099,595
+28.4%
0.02%
+71.4%
Q3 2020$11,171,000
+15.0%
856,6640.0%0.01%
+16.7%
Q2 2020$9,715,000
-26.0%
856,664
-6.6%
0.01%
-40.0%
Q1 2020$13,127,000
-47.3%
917,316
+0.2%
0.02%
-33.3%
Q4 2019$24,918,000
-6.7%
915,092
-1.9%
0.03%
-11.8%
Q3 2019$26,714,000
+622.4%
933,063
+600.8%
0.03%
+580.0%
Q2 2019$3,698,000
-16.3%
133,1350.0%0.01%
-16.7%
Q1 2019$4,420,000
+5.7%
133,135
-7.5%
0.01%0.0%
Q4 2018$4,183,000
-46.6%
143,886
-15.6%
0.01%
-33.3%
Q3 2018$7,840,000
-1.9%
170,437
-20.3%
0.01%
-10.0%
Q2 2018$7,994,000
+28.2%
213,914
+1.4%
0.01%
+25.0%
Q1 2018$6,235,000
-14.0%
211,0140.0%0.01%
-11.1%
Q4 2017$7,247,000
-4.0%
211,014
+1.1%
0.01%
-10.0%
Q3 2017$7,550,000
+23.9%
208,671
-11.5%
0.01%
+25.0%
Q2 2017$6,095,000
+36.2%
235,878
+1.2%
0.01%
+33.3%
Q1 2017$4,475,000
+81.8%
233,079
+57.8%
0.01%
+100.0%
Q4 2016$2,462,000
-25.2%
147,683
-7.6%
0.00%
-40.0%
Q3 2016$3,291,000
-61.7%
159,903
-43.1%
0.01%
-61.5%
Q2 2016$8,598,000
-24.0%
280,965
-7.1%
0.01%
-23.5%
Q1 2016$11,315,000
-6.7%
302,300
+7.6%
0.02%
-10.5%
Q4 2015$12,131,000
+1.3%
281,075
-12.0%
0.02%0.0%
Q3 2015$11,972,000
+10.4%
319,435
+0.1%
0.02%
+18.8%
Q2 2015$10,847,000
+11.5%
319,135
+16.1%
0.02%
+14.3%
Q1 2015$9,727,000
+216.2%
274,775
+204.3%
0.01%
+180.0%
Q4 2014$3,076,000
-65.6%
90,300
-60.7%
0.01%
-61.5%
Q2 2014$8,952,000
+13.8%
230,0000.0%0.01%
+8.3%
Q1 2014$7,864,000
+63.0%
230,0000.0%0.01%
+50.0%
Q4 2013$4,825,000
-60.0%
230,000
-55.2%
0.01%
-60.0%
Q3 2013$12,052,000
-9.0%
512,850
+4.1%
0.02%
-13.0%
Q2 2013$13,243,000492,8500.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$98,875,0003.47%
Tieton Capital Management, LLC 187,636$3,711,0002.72%
Glenview Capital Management 3,682,691$72,825,0001.67%
Altium Capital Management LP 218,650$4,324,0001.61%
S&T BANK/PA 331,098$6,547,0001.18%
EARNEST PARTNERS LLC 6,731,429$133,114,0000.92%
DISCIPLINED GROWTH INVESTORS INC /MN 2,078,075$41,094,0000.79%
SummerHaven Investment Management, LLC 35,700$706,0000.55%
AIMZ Investment Advisors, LLC 42,685$844,0000.44%
CONTINENTAL ADVISORS LLC 36,392$720,0000.33%
View complete list of MYRIAD GENETICS INC shareholders